Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Tobias F. Menne"'
Autor:
Anna Santarsieri, Katherine Sturgess, Pauline Brice, Tobias F. Menne, Wendy Osborne, Thomas Creasey, Kirit M. Ardeshna, Sarah Behan, Kaljit Bhuller, Stephen Booth, Nikesh Chavda, Graham P. Collins, Dominic Culligan, Kate Cwynarski, Andrew Davies, David Dutton, Michelle Furtado, Eve Gallop-Evans, Andrew Hodson, David Hopkins, Hannah Hsu, Sunil Iyengar, Stephen G. Jones, Kim Linton, Oliver Lomas, Nicolas Martinez-Calle, Abhinav Mathur, Pamela Mckay, Sateesh K. Nagumantry, Deidre O’Mahony, Beth Phillips, Neil Phillips, John F. Rudge, Nimish Shah, Gwyneth Stafford, Alex Sternberg, Rachel Trickey, Benjamin J. Uttenthal, Natasha Wetherall, Andrew K. Mcmillan, George A. Follows
Publikováno v:
HemaSphere, Vol 6, Pp 7-8 (2022)
Externí odkaz:
https://doaj.org/article/73e869b8b35c43ab9ad6239b781392e4
Autor:
Anna Santarsieri, Emily Mitchell, Katherine Sturgess, Pauline Brice, Tobias F. Menne, Wendy Osborne, Thomas Creasey, Kirit M. Ardeshna, Sarah Behan, Kaljit Bhuller, Stephen Booth, Nikesh D. Chavda, Graham P. Collins, Dominic J. Culligan, Kate Cwynarski, Andrew Davies, Abigail Downing, David Dutton, Michelle Furtado, Eve Gallop-Evans, Andrew Hodson, David Hopkins, Hannah Hsu, Sunil Iyengar, Stephen G. Jones, Kim M. Linton, Oliver C. Lomas, Nicolas Martinez-Calle, Abhinav Mathur, Pamela McKay, Sateesh K. Nagumantry, Deirdre O'Mahony, Elizabeth H. Phillips, Neil Phillips, John F. Rudge, Nimish K. Shah, Gwyneth Stafford, Alex Sternberg, Rachel Trickey, Benjamin J. Uttenthal, Natasha Wetherall, Andrew K. McMillan, Michael Stratton, Elisa Laurenti, Peter J. Campbell, George A. Follows
Publikováno v:
Blood. 140:1761-1764
Autor:
Stephen Boyle, Robin Sanderson, Maeve A. O'Reilly, Tobias F. Menne, Jane Norman, Adrian Bloor, Sanne Lugthart, Sridhar Chaganti, Carlos Gonzalez-Arias, Ceri Jones, Anne-Louise Latif, Reuben Benjamin, Piers Patten, Deborah Yallop, Victoria Potter, Claire Roddie, Andrea Kuhnl
Publikováno v:
Blood. 140:4649-4651
Autor:
David I Marks, Amy A Kirkwood, Clare J Rowntree, Melanie Aguiar, Katharine E Bailey, Brendan Beaton, Paul Cahalin, Anna Z Castleton, Laura Clifton-Hadley, Mhairi Copland, Anthony H Goldstone, Richard Kelly, Emma Lawrie, SooWah Lee, Andrew K McMillan, Mary Frances McMullin, Tobias F Menne, Rachel J Mitchell, Anthony V Moorman, Bela Patel, Pip Patrick, Paul Smith, David Taussig, Deborah Yallop, Krisztina Zuborne Alapi, Adele K Fielding
Publikováno v:
Marks, D I, Kirkwood, A A, Rowntree, C J, Aguiar, M, Bailey, K E, Beaton, B, Cahalin, P, Castleton, A Z, Clifton-Hadley, L, Copland, M, Goldstone, A H, Kelly, R, Lawrie, E, Lee, S, McMillan, A K, McMullin, M F, Menne, T F, Mitchell, R J, Moorman, A V, Patel, B, Patrick, P, Smith, P, Taussig, D, Yallop, D, Alapi, K Z & Fielding, A K 2022, ' Addition of four doses of rituximab to standard induction chemotherapy in adult patients with precursor B-cell acute lymphoblastic leukaemia (UKALL14): a phase 3, multicentre, randomised controlled trial ', The Lancet Haematology, vol. 9, no. 4, pp. e262-e275 . https://doi.org/10.1016/S2352-3026(22)00038-2
BACKGROUND: Treatment for adults with acute lymphoblastic leukaemia requires improvement. UKALL14 was a UK National Cancer Research Institute Adult ALL group study that aimed to determine the benefit of adding the anti-CD20 monoclonal antibody, ritux
Autor:
Junji Suzumiya, Seok-Goo Cho, Keum Young Ahn, Marek Trneny, Eduardo Yanez Ruiz, Christian Buske, Leslie Popplewell, Jose Mario Mariz, Michinori Ogura, Larry W. Kwak, Olga Samoilova, Tobias F. Menne, Hideyuki Nakazawa, Jin Seok Kim, Edvard Zhavrid, Gayane Tumyan, Nikolai Ilyin, Sunghyun Kim, Sang-Joon Lee, Wojciech Jurczak, Won Seog Kim, Juan-Manuel Sancho, A. Martínez
Publikováno v:
Clinical Lymphoma Myeloma & Leukemia
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname
INTRODUCTION: This double-blind, parallel-group, active-controlled phase III trial (NCT02260804) assessed CT-P10 and rituximab safety and efficacy in patients with previously untreated low-tumor-burden follicular lymphoma (LTBFL), including after a s
Autor:
Pip Patrick, Clare J. Rowntree, Andrew McMillan, Emma Lawrie, Krisztina Zuborne Alapi, Bela Patel, Laura Clifton-Hadley, Emilio Barretta, Adele K. Fielding, Rachel J. Mitchell, Anthony V. Moorman, Tobias F. Menne, Elli Papaemmanuil, David I. Marks, Soo Wah Lee, Amy A Kirkwood, Daniel Leongamornlert, Nahid Zareian
Publikováno v:
Blood Adv
IKZF1 deletions (ΔIKZF1) are commonly detected in B-precursor acute lymphoblastic leukemia (ALL; B-ALL) and are widely assumed to have a significant impact on outcome. We compared the ability of multiplex ligand-dependent probe amplification (MLPA)
Autor:
Kate Cwynarski, Gloria Iacoboni, Eleni Tholouli, Tobias F. Menne, David A. Irvine, Nivetha Balasubramaniam, Leigh Wood, Justin Shang, Yiyun Zhang, Silvia Basilico, Birgit Huber, Mary Vinson, Koki Lilova, Wolfram Brugger, Martin Pule
Publikováno v:
Blood. 140:10316-10317
Autor:
Kami J. Maddocks, Johannes Duell, Eva González-Barca, Wojciech Jurczak, Anna Marina Liberati, Sven de Vos, Zsolt Nagy, Aleš Obr, Gianluca Gaidano, Pau Abrisqueta, Marc André, Martin Dreyling, Tobias F Menne, Maren Dirnberger-Hertweck, Johannes Weirather, Sumeet Ambarkhane, Gilles Salles
Publikováno v:
Blood. 136:19-21
Introduction Patients with relapsed/refractory (R/R) diffuse large B-cell lymphoma (DLBCL) who are not eligible for autologous stem cell transplant (ASCT) have a poor prognosis. Tafasitamab (MOR208) is an Fc-enhanced, humanized, monoclonal antibody t
Acute lymphoblastic leukaemia (ALL) is a malignant proliferation of lymphoid blasts, most commonly of B-lineage origin. The clinical symptoms and signs are either a consequence of bone marrow failure (infections, bruising, petechiae, pallor, and tire
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e48b721525bfac56bc892049db081089
https://doi.org/10.1093/med/9780198746690.003.0523
https://doi.org/10.1093/med/9780198746690.003.0523
Autor:
Laura Clifton-Hadley, Tobias F. Menne, Anthony V. Moorman, Amy A Kirkwood, Marc R. Mansour, Nadine Farah, Andrew McMillan, Clare Rowntree, Adele K. Fielding, Jiaull Hussain, Bela Wrench, Pip Patrick, David I. Marks
Publikováno v:
Blood. 138:366-366
Background: Between April 2012 and July 2018, adult patients aged 25-65 years with newly diagnosed T-cell acute lymphoblastic leukaemia (T-ALL) in 48 UK centres were randomised at trial entry to receive standard of care (SOC) ALL induction phases I a